Altered Gut Microbiome and Fecal Immune Phenotype in Early Preterm Infants With Leaky Gut

Jose M Lemme-Dumit1,2, Yang Song3, Hnin Wai Lwin3

  • 1Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.

Insights

Immune responses and gut bacteria impact intestinal barrier maturation in preterm infants. Specific microbiota and cytokines like IL-1α/β are linked to lower intestinal permeability, promoting gut health.

Area of Science:

  • Neonatal immunology
  • Gastroenterology
  • Microbiome research

Background:

  • Intestinal barrier immaturity, or "leaky gut," increases necrotizing enterocolitis risk in preterm neonates.
  • Gut microbiota dysbiosis and immune responses are key factors in aberrant intestinal maturation.
  • The specific immune elements driving gut maturation remain largely uncharacterized.

Purpose of the Study:

  • To investigate fecal cytokine profiles and gut microbiota in preterm infants.
  • To identify immune markers associated with intestinal barrier maturation.
  • To understand the interplay between microbiota, immunity, and intestinal permeability.

Main Methods:

  • Analysis of fecal cytokine profiles and gut microbiota composition.
  • Study cohort: 40 preterm infants (<33 weeks gestation).
  • Correlation of microbiota types with intestinal permeability and feeding patterns.

Main Results:

  • Three distinct microbiota types were identified, differentially associated with intestinal permeability (IP), breast milk feeding, and immune profiles.
  • Staphylococcus epidermidis- and Enterobacteriaceae-predominant microbiota correlated with elevated IP and reduced breast milk feeding.
  • Lower IP was associated with increased fecal IL-1α/β and a diverse anaerobic microbiota with high fermentative capacity.

Conclusions:

  • Both immunological and microbiological factors critically influence early intestinal barrier development.
  • These factors collectively shape the intestinal microenvironment, impacting gut homeostasis and maturation in preterm newborns.
  • Identifying specific immune and microbial markers can aid in understanding and potentially improving gut health in vulnerable neonates.